Distribution of chimeric antigen receptor-modified T cells against CD19 in B-cell malignancies

被引：0
|
作者：
Zhitao Ying
Ting He
Xiaopei Wang
Wen Zheng
Ningjing Lin
Meifeng Tu
Yan Xie
Lingyan Ping
Chen Zhang
Weiping Liu
Lijuan Deng
Meng Wu
Feier Feng
Xin Leng
Tingting Du
Feifei Qi
Xuelian Hu
Yanping Ding
Xin-an Lu
Yuqin Song
Jun Zhu
机构：
[1] Peking University Cancer Hospital & Institute,Department of Lymphoma, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing)
[2] Beijing Immunochina Pharmaceuticals Co.,undefined
[3] Ltd.,undefined
来源：
BMC Cancer | / 21卷
关键词：
CAR-T; Biodistribution; B-ALL; B-NHL; Blood;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [41] Chimeric antigen receptor-modified T cells strike back
    Frigault, Matthew J.
    Maus, Marcela V.
    INTERNATIONAL IMMUNOLOGY, 2016, 28 (07) : 355 - 363
  • [42] Chimeric Antigen Receptor (CAR) T Cells Targeting the CD19 Antigen for the Treatment of Pediatric Relapsed B Cell ALL
    Curran, Kevin J.
    Riviere, Isabelle
    Kobos, Rachel
    Kernan, Nancy A.
    Boulad, Farid
    Prockop, Susan E.
    Scaradavou, Andromachi
    Renaud, Thomas M.
    Shukla, Neerav
    Steinherz, Peter G.
    Park, Jae H.
    Sauter, Craig S.
    O'Reilly, Richard J.
    Sadelain, Michel
    Brentjens, Renier J.
    BLOOD, 2014, 124 (21)
  • [43] Addition of Fludarabine to Cyclophosphamide Lymphodepletion Improves In Vivo Expansion of CD19 Chimeric Antigen Receptor-Modified T Cells and Clinical Outcome in Adults with B Cell Acute Lymphoblastic Leukemia
    Turtle, Cameron J.
    Hanafi, Laila-Aicha
    Berger, Carolina
    Sommermeyer, Daniel
    Pender, Barbara
    Robinson, Emily M.
    Melville, Katherine
    Budiarto, Tanya M.
    Steevens, Natalia N.
    Chaney, Colette
    Cherian, Sindhu
    Wood, Brent L.
    Soma, Lorinda
    Chen, Xueyan
    Heimfeld, Shelly
    Jensen, Michael C.
    Riddell, Stanley R.
    Maloney, David G.
    BLOOD, 2015, 126 (23)
  • [44] Infectious complications of CD19-targeted chimeric antigen receptor-modified T-cell immunotherapy
    Hill, Joshua A.
    Li, Daniel
    Hay, Kevin A.
    Green, Margaret L.
    Cherian, Sindhu
    Chen, Xueyan
    Riddell, Stanley R.
    Maloney, David G.
    Boeckh, Michael
    Turtle, Cameron J.
    BLOOD, 2018, 131 (01) : 121 - 130
  • [45] Donor-derived CD19 chimeric antigen receptor T cells
    Singh, Nathan
    Barrett, David M.
    CURRENT OPINION IN HEMATOLOGY, 2015, 22 (06) : 503 - 508
  • [46] Chimeric antigen receptor modified T cell therapy for B cell malignancies
    Turtle, Cameron J.
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2014, 99 (02) : 132 - 140
  • [47] Chimeric antigen receptor modified T cell therapy for B cell malignancies
    Cameron J. Turtle
    International Journal of Hematology, 2014, 99 : 132 - 140
  • [48] In vivo and in vitro studies and molecular mechanisms of chimeric antigen receptor T cells against CD19
    Wang, R.
    Yang, S.
    Yang, L.
    Li, L.
    Wang, W.
    Meng, M.
    Tan, J.
    Zhao, Y.
    Gao, H.
    Tang, W.
    Yang, L.
    Liao, L.
    Hou, Z.
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2019, 49 : 1716 - 1716
  • [49] Targeting T-cell Leukemia with CD5-Based Chimeric Antigen Receptor-Modified γδ T Cells
    Fleischer, Lauren C.
    Zoine, Jaquelyn T.
    Ryan, Rebecca E.
    Raikar, Sunil S.
    Doering, Christopher B.
    Spencer, H. Trent
    MOLECULAR THERAPY, 2018, 26 (05) : 57 - 57
  • [50] CD19 Chimeric Antigen Receptor T Cell Treatment: Unraveling the Role of B Cells in Systemic Lupus Erythematosus
    Taubmann, Jule
    Mueller, Fabian
    Mutlu, Melek Yalcin
    Voelkl, Simon
    Aigner, Michael
    Bozec, Aline
    Mackensen, Andreas
    Grieshaber-Bouyer, Ricardo
    Schett, Georg
    ARTHRITIS & RHEUMATOLOGY, 2024, 76 (04) : 497 - 504
12345